The shares of The Meet Group, Inc. (NASDAQ:MEET) has been pegged with a rating of Outperform by Oppenheimer in its latest research note that was published on June 21st, 2019. The research company has also assigned a $7 price target. Oppenheimer wasn’t the only research firm that published a report of The Meet Group, Inc., with other equities research analysts also giving their opinion on the stock. Aegis Capital advised investors in its research note published on May 15th, 2019, to Buy the MEET stock while also putting a $6.25 price target. The stock had earned Buy rating from ROTH Capital when it published its report on March 8th, 2018. That day the ROTH Capital set price target on the stock to $3.25. The stock was given Mkt Perform rating by JMP Securities in its report released on November 9th, 2017. JMP Securities was of a view that MEET is Mkt Outperform in its latest report on August 7th, 2017 while giving it a price target of $6. Canaccord Genuity thinks that MEET is worth Buy rating. This was contained in the firm’s report on March 20th, 2017 in which the stock’s price target was also moved to $10.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 0 believe it has the potential for further growth, thus rating it as Hold while 3 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $6.60. The price of the stock the last time has raised by 24.59% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 63.31.
The shares of the company added by 4.68% during the trading session on Thursday, reaching a low of $3.60 while ending the day at $3.80. During the trading session, a total of 1.43 million shares were traded which represents a -7.47% decline from the average session volume which is 1.33M shares. MEET had ended its last session trading at 3.63. The Meet Group, Inc. currently has a market cap of $286.44M, while its P/E ratio stands at 32.20, while its P/E earnings growth sits at 1.43, with a beta of 1.48. The Meet Group, Inc. debt-to-equity ratio currently stands at 0.16, while its quick ratio hovers at 1.20. MEET 52-week low price stands at $3.05 while its 52-week high price is $6.27.
The company in its last quarterly report recorded $0.11 earnings per share which is above the $0.10 predicted by most analysts. The The Meet Group, Inc. generated $52.00 million in revenue during the last quarter, which is slightly higher than the $50.83 million predicted by analysts. In the second quarter last year, the firm recorded $0.09 earnings per share. Compared to the same quarter last year, the firm’s revenue was up by 18.18%. The Meet Group, Inc. has the potential to record 0.12 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Robert W. Baird published a research note on August 2nd, 2019 where it informed investors and clients that Iron Mountain Incorporated (NYSE:IRM) is now rated as Neutral. Their price target on the stock stands at $29. Aegis Capital also rated IRM as Initiated on May 15th, 2019, with its price target of $12 suggesting that IRM could surge by 10.03% from its current share price. Even though the stock has been trading at $31.72/share, analysts expect it to surge higher by -0.22% to reach $35.18/share. It started the day trading at $31.89 and traded between $31.56 and $31.65 throughout the trading session.
A look at its technical shows that IRM’s 50-day SMA is 31.04 while its 200-day SMA stands at 33.25. The stock has a high of $37.32 for the year while the low is $29.28. The company’s P/E ratio currently sits at 25.34, while the P/B ratio is 5.48. At the moment, only of Iron Mountain Incorporated shares were sold short. The company’s average trading volume currently stands at 2.92M shares, which means that the short-interest ratio is just 13.79 days. Over the past seven days, the company moved, with its shift of 2.13%. Looking further, the stock has dropped -0.25% over the past 90 days while it lost -11.05% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more IRM shares, increasing its portfolio by +2.51% during the last quarter. This move now sees The Vanguard Group Inc purchasing 1,108,753 shares in the last quarter, thus it now holds 45,349,617 shares of IRM, with a total valuation of $1,333,732,236. Capital Research Management Co meanwhile sold more IRM shares in the recently filed quarter, changing its stake to $948,411,357 worth of shares. BlackRock Fund Advisors followed the path by increasing its IRM portfolio by +2.18% in the quarter. This means that BlackRock Fund Advisors bought 338,391 shares in the last quarter and now controls 15,881,083 shares of the IRM stock, with the valuation hitting $467,062,651.
Similarly, Goldman Sachs Co LLC increased its Iron Mountain Incorporated shares by +29.92% during the recently filed quarter. After buying 2,057,480 shares in the last quarter, the firm now controls 8,934,155 shares of Iron Mountain Incorporated which are valued at $262,753,499. In the same vein, Capital Research Management Co decreased its Iron Mountain Incorporated shares by during the most recent reported quarter. The firm sold -1,211,084 shares during the quarter which decreased its stakes to 7,590,822 shares and is now valued at $223,246,075. Following these latest developments, around 1.00% of Iron Mountain Incorporated stocks are owned by institutional investors and hedge funds.